QiC Oncology Blog


UK landmarks turn pink for breast cancer

Several major UK landmarks turned pink this week in support of a breast cancer campaign.

Cancer Drugs Fund gets £160m extra funding

The Government announced today that England’s Cancer Drugs Fund (CDF) will receive £160m more in funding over the next two years.

Stars come out for Bowel Cancer UK campaign

Several well-known figures in the UK have pledged their support for a new cancer campaign run by Bowel Cancer UK.

Macmillan campaign to leave a legacy after death

Macmillan Cancer Support’s new campaign and film – ‘Live Your Legacy’ – aim to encourage people across the UK to consider how they would like to be remembered after they die.

Tattoo artists enlisted to raise awareness of skin cancer

Tattoos are being used as part of a campaign in Brazil to raise awareness of the symptoms of skin cancer.

Sharing ideas, to improve care for cancer patients - part 1

Projects covering safe and seamless nursing care at home, cancer chemotherapy commissioning and coordinating cancer care across different sites are among the case studies to be presented in a forthcoming webinar.

Webinars to share ideas on how to improve care for cancer patients

QiC Excellence is hosting two webinars featuring speakers behind award-winning programmes in cancer care.

Target Ovarian Cancer raises concerns about drugs access

The patient group Target Ovarian Cancer has added its voice to the list of organisations concerned about future access to cancer medicines in England and Wales once the Cancer Drugs Fund closes in 2014.

Presentations of award-winning programmes in oncology and diabetes

In March this year, the Healthcare Innovation Expo heard how NHS teams developed innovative ideas and solutions to improve patient outcomes and experience in diabetes and oncology.

Beating Bowel Cancer warns of future access to cancer drugs

Beating Bowel Cancer – a supporter of QiC Excellence in Oncology – has warned the government that a lack of guidance on the future of England’s Cancer Drugs Fund (CDF) is causing undue worry for cancer patients.

Supported by: